Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems

European Journal of Pharmacology

Volumn 332, Issue 1, 1997, Pages 15-21

  Huang, Wenhao ^a   Hanson, Glen R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Dopamine; Haloperidol; Neurotensin; Nucleus accumbens; Striatum

Indexed keywords

DOPAMINE RECEPTOR; HALOPERIDOL; NEUROTENSIN; RECEPTOR SUBTYPE; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; EXTRAPYRAMIDAL SYSTEM; IMMUNOREACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; NERVE ENDING; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PERIKARYON; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; ANTI-DYSKINESIA AGENTS; EXTRAPYRAMIDAL TRACTS; HALOPERIDOL; IMMUNE SYSTEM; LIMBIC SYSTEM; MALE; NEUROTENSIN; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TIME FACTORS; VENTRAL TEGMENTAL AREA; VISUAL CORTEX;

EID: 0030837438     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01032-7     Document Type: Article

References (26)

1. Alexander, M.J., Miller, M.A., Dorsa, D.M., Bullock, B.P., Melloni, R.H. Jr., Dobner, P.R., Leeman, S.E., 1989. Distribution of neurotensin/neuromedin N mRNA in rat forebrain: Unexpected abundance in hippocampus and subiculum. Proc. Natl. Acad. Sci. USA 86, 5202-5206.
2. 2 receptors. Eur. J. Pharmacol. 177, 111-118.
3. Bradford, M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Frey, P., Fuxe, K., Eneroth, P., Agnoati, L., 1986. Effects of acute and long-term treatment with neuroleptics on regional telencephalic neurotensin levels in the male rat. Neurochem. Int. 429-432.
5. Govoni, S., Hong, J.S., Yang, H.-Y., Costa, E., 1980. Increase of neurotensin content elicited by neuroleptics in nucleus accumbens. J. Pharmacol. Exp. Ther. 215, 413-417.
6. 2 receptor. Clin. Neuropharmacol. 18 (Suppl. 1), S130-S142.
7. 3 receptor and schizophrenia: Pharmacological, anatomical and genetic approaches. Eur. Neuropsychopharmacol. Suppl. 3-9.
8. Gygi, S.P., Gibb, J.W., Hanson, G.R., 1994. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions. J. Pharmacol. Exp. Ther. 270, 192-197.
9. Kitabgi, P., 1989. Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways. Neurochem. Int. 14, 111-119.
10. Konkoy, C.S., Waters, S.M., Davis, T.P., 1994. Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices. J. Pharmacol. Exp. Ther. 269, 555-563.
11. Lang, A., Soosaar, A., Koks, S., Volke, V., Bourin, M., Bradwejn, J., Vasar, E., 1994. Pharmacological comparison of antipsychotic drugs and sigma-antagonists in rodents. Pharmacol. Toxicol. 75, 222-227.
12. Levant, B., Nemeroff, C.B., 1990. Sigma receptor 'antagonist' BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate. J. Pharmacol. Exp. Ther. 254, 330-335.
13. Levant, B., Bissette, G., Nemeroff, C.B., 1989. Effects of anticholinergic drugs on regional brain neurotensin concentrations. Eur. J. Pharmacol. 165, 327-330.
14. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. Natl. Acad. Sci. USA 92, 1719-1723.
15. Maidment, N.T., Siddall, B.J., Rudolph, V.R., Erdelyi, E., Evans, C.J., 1991. Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassay. Neurosci. 45, 81-93.
16. Merchant, K.M., Dobner, P.R., Dorsa, D.M., 1992. Differential effects of haloperidol and clozapine in neurotensin gene transcription in rat neostriatum. J. Neurosci. 12, 652-663.
17. Merchant, K.M., Bush, L.G., Gibb, J.W., Hanson, G.R., 1989. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain. Brain Res. 500, 21-29.
18. Merchant, K.M., Miller, M.A., Ashleigh, E.A., Dorsa, D.M., 1991. Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in the neostriatum of the rat brain. Brain Res. 540, 311-314.
19. Myers, B., Levant, B., Bissette, G., 1992. Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment. Brain Res. 575, 325-328.
20. Nemeroff, C.B., Hernandez, D.E., Luttinger, D., Kalivas, P.W., Prange, A.J. Jr., 1982. Interactions of neurotensin with brain dopamine systems. Ann. N.Y. Acad. Sci. 400, 330-344.
21. Nemeroff, C.B., 1986. The interaction of neurotensin with dopaminergic pathways in the central nervous system: Basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinology 11, 15-37.
22. Onn, S.P., Grace, A.A., 1995. Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens. J. Neurosci. 15, 7024-7036.
23. Quirion, R., 1983. Interactions between neurotensin and dopamine in the brain: An overview. Peptides 4, 609-612.
24. Sokoloff, P., Diaz, J., Levesque, D., Pilon, C., Dimitriadou, V., Griffon, N., Lammers, C.H., Martres, M.P., Schwartz, J.C., 1995. Novel dopamine receptor subtypes as targets for antipsychotic drugs. Ann. N.Y. Acad. Sci. 757, 278-292.
25. 2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Res. 721, 196-203.
26. Widerlov, E., Lindstrom, L.H., Besev, G., Manberg, P.J., Nemeroff, C.B., Breese, G.R., Kizer, J.S., Prange, A.J. Jr., 1982. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: Normalization after neuroleptic treatment. Am. J. Psychiatry 139, 1122-1126.